Progressive external ophthalmoplegia, autosomal dominant, type 1 (Q97268): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Created a new Item
 
‎Changed an Item
 
(6 intermediate revisions by the same user not shown)
description / pt-brdescription / pt-br
 
Oftalmoplegia externa progressiva autossômica dominante com deleções-1 do DNA mitocondrial (PEOA1) é causada pela mutação no gene DNA polimerase-gama (POLG; 17763) no cromossomo 15q25. As características clínicas mais comuns incluem início na idade adulta de fraqueza dos músculos externos do olho e intolerância ao exercício. Sintomas adicionais são variáveis e podem incluir catarata, perda auditiva, neuropatia sensorial axonal, ataxia, depressão, hipogonadismo e parkinsonismo. Oftalmoplegia externa progressiva causada pela mutação no gene POLG é associada com fenótipos mais complicados que as formas causadas pela mutação nos genes ANT1 e C10ORF2.
description / endescription / en
 
Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Progressive external ophthalmoplegia caused by mutation in the POLG gene is associated with more complicated phenotypes than those forms caused by mutation in the ANT1 or C10ORF2 genes.
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/1743854054 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_1743854054
Property / CURIE: CID11:ID_1743854054 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_1743854054
Property / Canary Token: dki-india-ID_1743854054 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
15 August 2026
Timestamp+2026-08-15T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 15 August 2026 / rank
 
Normal rank

Latest revision as of 13:21, 16 August 2026

Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Progressive external ophthalmoplegia caused by mutation in the POLG gene is associated with more complicated phenotypes than those forms caused by mutation in the ANT1 or C10ORF2 genes.
Language Label Description Also known as
default for all languages
ID_1743854054
    English
    Progressive external ophthalmoplegia, autosomal dominant, type 1
    Autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions-1 (PEOA1) is caused by mutation in the nuclear-encoded DNA polymerase-gamma gene (POLG; 174763) on chromosome 15q25. The most common clinical features include adult onset of weakness of the external eye muscles and exercise intolerance. Additional symptoms are variable, and may include cataracts, hearing loss, sensory axonal neuropathy, ataxia, depression, hypogonadism, and parkinsonism. Progressive external ophthalmoplegia caused by mutation in the POLG gene is associated with more complicated phenotypes than those forms caused by mutation in the ANT1 or C10ORF2 genes.

      Statements

      CID11:ID_1743854054
      0 references
      dki-india-ID_1743854054
      0 references
      Concluído
      0 references
      15 August 2026
      0 references